Download Lecture 22

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Control of Energy
The Original Biofuels
Importance of Glucose Regulation
• Too little – Brain problems
• Too much
– Osmotic water loss (cellular and systemic)
– Damages blood vessels
Role of the Pancreas
1. Digestion – secretes digestive enzymes
2. Metabolism
•
Regulation
•
•
•
•
Carbohydrates
Lipids
Proteins
Produces primary messengers (hormones)
•
•
Insulin
Glucagon
•
•
Insulin discovered by
Frederick Banting and Charles
Best in 1921.
Leonard Thompson (age 14,
65lbs) first patient successfully
treated.
• 51 amino acids
• 2 chains linked by disulfide bonds
• 5800 Dalton molecular weight
Effects of Insulin
• Nearly all cells (80%) increase glucose
uptake (seconds)
– Active transport
– Primarily affects liver and muscle
– Brain tissue is excepted
• Alters phosphorylation of many key
intracellular metabolic enzymes (minutes)
• Alters protein synthesis and gene
transcription (hours)
Insulin Affects Tissues Differently
• Muscle
– Uptake of glucose and immediate use (exercise)
or storage as glycogen (Exercising muscles can
take up glucose without insulin)
• Liver
– Uptake of glucose and storage as glycogen
•
•
•
•
Inhibits glycogen phosphorylase
Activates glycogen synthase
Inhibits glucose synthesis
Promotes excess glucose conversion to fatty acids
• Adipose Tissue
– Promotes glucose uptake and conversion to
glycerol for fat production
Insulin and Fat Metabolism
• Liver cells store glycogen only up to 5-6%
– Remaining glucose metabolized to fat
– Triglycerides are synthesized and release into blood
• Adipose cells store fat
– Inhibits breakdown of triglycerides
– Stimulates uptake and use of glucose to form glycerol
– Stimulates fatty acid uptake and conversion to triglycerides
• Lack of insulin
– Free fatty acids build up in blood
– Liver metabolizes to produce phospholipids and cholesterol
– Can lead to excess acetoacetic acid production and buildup of
acetone (acidosis, which can lead to blindness and coma)
Insulin and Protein Metabolism
• Promotes
– Transport of amino acids
– Protein synthesis
– Gene transcription
• Inhibits protein degradation
• Prevents glucose synthesis in liver
– Preserves amino acids
• Lack of insulin causes elimination of
protein stores
Most Cells
Insulin
Control
 Protein synthesis
Muscle
 Glucose uptake
 Glycogen synthesis
Gastrointestinal
hormones
Adipose
Amino
acids
Pancreas
 amino
acids
 Insulin
 triglycerides
 Glucose uptake
 Glycerol production
 Triglyceride breakdown
 Triglyceride synthesis
Beta cells
Liver
Blood
glucose
 Glucose uptake
 Glycogen synthesis
 Fatty acid synthesis
 Glucose synthesis
Brain
No effect
Feedback
 glucose
Effects of Glucagon
• Prevents hypoglycemia
– Powerful system to degrade glycogen
– Increases glucose synthesis from amino
acids
• Increases with exercise independent of
blood glucose
• Exerts effects through cAMP second
messenger system
1)
2)
β – adrenergic
stimulation
glucagon
Glucagon
Control
 Triglyceride breakdown
 Triglyceride storage
Exercise
Amino acids
Adipose
 Fatty acids
Pancreas
Alpha cells
Epinephrine
(stress)
Liver
 Glycogen breakdown
 Glucose synthesis
 Glucose release
Brain
No effect
Feedback
 Blood glucose
Importance of Glucose Regulation
• Too little – Brain problems
• Too much
– Osmotic water loss (cellular and systemic)
– Damages blood vessels
Diabetes Mellitus
• Type I
– Insulin dependent
– Juvenile onset
– Causes
• Increased blood glucose (300-1,200 mg/100ml)
• Increased blood fatty acids and cholesterol
• Protein depletion
– Treated with insulin injections
– Increases risk of heart disease and stroke
– Can cause acidosis and coma
Diabetes Mellitus
• Type II
– Non-insulin dependent
– Results from insulin insensitivity
– Elevated insulin levels
– Associated with obesity
– Can lead to insulin dependent form
– Treated with weight loss, diet restriction,
exercise and drugs
Diabetes
• 143 million suffer worldwide (W.H.O.)
– Expected to double by 2025
– Costs $143B annually
• Treatment with insulin is not optimal
– Does not mimic normal control system
– Associated with serious health risks
• Direct transplantation has not proven feasible
– Immunosuppression causes problems
• Use of semi permeable encapsulation may be possible
–
–
–
–
Must optimize for nutrient exchange but immune isolation
Biocompatible and structurally sound
Prevent allergic responses
Must provide glucose control
• Other options may be effective (e.g., gene therapy)
Microencapsulation Approach